Continuous glucose monitoring (CGM) sensors are portable devices that allow measuring
and visualizing the glucose concentration in real time almost continuously for several days …

Control of blood glucose is essential for diabetes management. Current digital therapeutic
approaches for subjects with type 1 diabetes mellitus such as the artificial pancreas and …

Background Blood glucose (BG) management is crucial for type-1 diabetes patients
resulting in the necessity of reliable artificial pancreas or insulin infusion systems. In recent …

Continuous subcutaneous insulin infusion pumps and continuous glucose monitors enable
individuals with type 1 diabetes to achieve tighter blood glucose control and are critical …

Purpose We introduce two validated single (SH) and dual hormone (DH) mathematical
models that represent an in-silico virtual patient population (VPP) for type 1 diabetes (T1D) …

Due to increasing prevalence of diabetes as well as increasing management costs, the
artificial control of diabetes is a highly important task. Model-based design allows finding …

The last decade has seen tremendous improvements in technologies for Type 1 Diabetes
(T1D) management, in particular the so-called artificial pancreas (AP), a wearable closed …

Background: Continuous glucose monitors (CGMs) provide real-time interstitial glucose
concentrations that are essential for automated treatment of individuals with type 1 diabetes …

Objective: The artificial pancreas (AP) is an innovative closed-loop system for type 1
diabetes therapy, in which insulin is infused by portable pumps and insulin dosage is …

Background: Insulin infusion set failure resulting in prolonged hyperglycemia or diabetic
ketoacidosis can occur with pump therapy in type 1 diabetes. Set failures are frequently …